SOPHiA GENETICS (SOPH) Financials: Revenue & Earnings
SOPH$7.89+0.03 +0.32%
$672.08M
Market Cap
-6.39
P/E
789.50
Forward P/E
—
Score
SOPHiA GENETICS (SOPH) Financials: Revenue & Earnings
SOPH price $7.89 +0.03 +0.32%
- Ticker
- SOPH
- Price
- $7.89
- Change
- +0.03 +0.32%
- Market cap ?
- $672.08M
- P/E ?
- -6.39
- Forward P/E ?
- 789.50
- Dividend yield ?
- 0.00%
- Beta ?
- 0.95
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
Financials
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 25362000 | 28400000 | 40450000 | 47560000 | 62371000 | 65173000 | 77271000 |
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals…
Earnings and financials
SOPHiA GENETICS S.A. (SOPH) trades at $7.89, with a market cap of $672.08M and a trailing P/E of -6.39. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 25362000 | 28400000 | 40450000 | 47560000 | 62371000 | 65173000 | 77271000 |
Insights · Dividends · Forecast · Financials · Learn